Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L01 ANTINEOPLASTIC AGENTS
      L01X OTHER ANTINEOPLASTIC AGENTS
        L01XE Protein kinase inhibitors
          L01XE06 Dasatinib [DG:DG00714]
            D06414  Dasatinib (USAN) <JP/US>

USP drug classification [BR:br08302]
  Antineoplastics
    Molecular Target Inhibitors
      Dasatinib [DG:DG00714]
        D06414  Dasatinib (USAN)

Therapeutic category of drugs in Japan [BR:br08301]
  4  Agents affecting cellular function
    42  Antineoplastics
      429  Miscellaneous
        4291  Other Antitumors
          D06414  Dasatinib (USAN); Dasatinib hydrate (JAN)	L01XE06

Target-based classification of drugs [BR:br08310]
  Protein kinases
    Receptor tyrosine kinases (RTK)
      PDGFR family
        PDGFRB [HSA:5159] [KO:K05089]
          D06414  Dasatinib (USAN) <JP/US>
        KIT (CD117) [HSA:3815] [KO:K05091]
          D06414  Dasatinib (USAN) <JP/US>
      EPH family
        EPHA2 [HSA:1969] [KO:K05103]
          D06414  Dasatinib (USAN) <JP/US>
    Non-receptor tyrosine kinases
      SRC family
        SRC [HSA:6714] [KO:K05704]
          D06414  Dasatinib (USAN) <JP/US>
        FYN [HSA:2534] [KO:K05703]
          D06414  Dasatinib (USAN) <JP/US>
        LCK [HSA:3932] [KO:K05856]
          D06414  Dasatinib (USAN) <JP/US>
        YES1 [HSA:7525] [KO:K05705]
          D06414  Dasatinib (USAN) <JP/US>
      ABL family
        BCR-ABL [HSA_VAR:25v2] [HSA:25] [KO:K06619]
          D06414  Dasatinib (USAN) <JP/US>

[ BRITE | KEGG2 | KEGG ]